Brief: New Nordic Healthbrands Jan-March EBITDA Rises To SEK 8.5 Mln
April 25 (Reuters) - New Nordic Healthbrands AB NWND.ST :
* JAN-MARCH NET SALES AMOUNTED TO MSEK 103.7 (88.4), AN
INCREASE
OF 17.3 PER CENT
* JAN-MARCH EBITDA INCREASED TO MSEK 8.5 (7.3)
* JAN-MARCH OPERATING PROFIT INCREASED TO MSEK 8.4 (7.1)
Source text for Eikon: ID:nBQN64MB35
Further company coverage: NWND.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on New Nordic Healthbrands AB
See all newsBrief: New Nordic Healthbrands Reports Q2 EBIT Of SEK 9.0 Mln
Brief: New Nordic Healthbrands AB Q1 Group's Net Sales In Sek Decreased By 7.9% To Sek 132.5 Million
Brief: New Nordic Healthbrands Q4 Operating Profit Up At SEK 3.7 Mln
Brief: New Nordic Healthbrands Q3 Operating Profit SEK 2.7 Mln
Brief: New Nordic Healthbrands Q2 Net Sales Up At SEK 143.0 Mln